Treatment of Postpartum Hemorrhage With Blood Products in a Tertiary Hospital
Authors:
Open Access
- 10 July 2016
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 22 (7) , 685-692
Abstract
Postpartum hemorrhage (PPH) remains a leading cause of maternal mortality and morbidity worldwide. This retrospective observational study describes patient characteristics and hemostatic therapies administered to 352 parturients experiencing PPH and analyzes risk factors for developing severe PPH. During the study period, bleeding was controlled in all cases and 99.4% survived. The majority (98%) of patients received packed red blood cells. The most frequent hemostatic therapies administered were fibrinogen concentrate (56%), fresh frozen plasma (49%), and platelets (30%). A total of 124 (35%) women experienced severe PPH. Significant independent predictors for evolution to severe PPH were age, obstetric comorbidity, and plasma fibrinogen concentration. The latter was based on records from 267 (76%) patients. Plasma fibrinogen concentration before labor was the only modifiable prepartum risk factor independently associated with severe PPH, indicating that fibrinogen monitoring is warranted in these patients.Keywords
This publication has 25 references indexed in Scilit:
- Management of severe perioperative bleedingEuropean Journal of Anaesthesiology, 2013
- Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage studyIntensive Care Medicine, 2011
- Trends in postpartum hemorrhage: United States, 1994–2006American Journal of Obstetrics and Gynecology, 2010
- Blood Product Replacement for Postpartum HemorrhageClinical Obstetrics and Gynecology, 2010
- Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative GroupBMC Pregnancy and Childbirth, 2009
- Investigation of an increase in postpartum haemorrhage in CanadaBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Obstetric critical care: A blueprint for improved outcomesCritical Care Medicine, 2006
- WHO analysis of causes of maternal death: a systematic reviewThe Lancet, 2006
- Incidence of severe pre‐eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population‐based study: the MOMS‐B surveyBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Incidence and predictors of severe obstetric morbidity: case-control studyCommentary: Obstetric morbidity data and the need to evaluate thromboembolic diseaseBMJ, 2001